FY24-FY33 NIAID-DLA Pharmaceutical Vendor Program
$610,000Y01FY2024AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
The NIAID-DLA IAA enables DAIT/ NIAID to purchase brand name pharmaceutical products (ie: biologics) at a significantly discounted (50-60% cheaper) price for use in NIAID-supported clinical trials.
View original record on NIH RePORTER →